The prognostic value of interim positron emission tomography scans combined with immunohistochemical data in diffuse large B-cell lymphoma

Keyphrases

• B-cell Lymphoma 2 (Bcl-2) 100%
• BCL6 50%
• Biological Characteristics 50%
• Biological Response 50%
• Diffuse Large B-cell Lymphoma (DLBCL) 100%
• Direct Therapy 50%
• Hematological Malignancies 50%
• Interim Positron Emission Tomography 100%
• Outcome Prediction 50%
• Positron Emission Tomography 100%
• Prognostic Information 50%
• Prognostic Value 100%
• Remission 50%
• Response to Treatment 50%
• Risk Stratification 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Diffuse Large B Cell Lymphoma 100%
• Disease 100%
• Hematologic Malignancy 100%
• Remission 100%

Medicine and Dentistry

• Diffuse Large B-Cell Lymphoma 100%
• Disease 50%
• Hematologic Malignancy 50%
• Positron Emission Tomography 100%